BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 27521055)

  • 1. Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics.
    Goel S; England CG; Chen F; Cai W
    Adv Drug Deliv Rev; 2017 Apr; 113():157-176. PubMed ID: 27521055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
    Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
    Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: an overview.
    Chakravarty R; Goel S; Dash A; Cai W
    Q J Nucl Med Mol Imaging; 2017 Jun; 61(2):181-204. PubMed ID: 28124549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles and radiotracers: advances toward radionanomedicine.
    Pratt EC; Shaffer TM; Grimm J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):872-890. PubMed ID: 27006133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breaking the Depth Dependence by Nanotechnology-Enhanced X-Ray-Excited Deep Cancer Theranostics.
    Fan W; Tang W; Lau J; Shen Z; Xie J; Shi J; Chen X
    Adv Mater; 2019 Mar; 31(12):e1806381. PubMed ID: 30698854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography imaging using radiolabeled inorganic nanomaterials.
    Sun X; Cai W; Chen X
    Acc Chem Res; 2015 Feb; 48(2):286-94. PubMed ID: 25635467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles for SPECT and PET Imaging: Towards Personalized Medicine and Theranostics.
    Polyak A; Ross TL
    Curr Med Chem; 2018; 25(34):4328-4353. PubMed ID: 28875837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in carbon based nanosystems for cancer theranostics.
    Augustine S; Singh J; Srivastava M; Sharma M; Das A; Malhotra BD
    Biomater Sci; 2017 May; 5(5):901-952. PubMed ID: 28401206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions.
    Farzin L; Sheibani S; Moassesi ME; Shamsipur M
    J Biomed Mater Res A; 2019 Jan; 107(1):251-285. PubMed ID: 30358098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable Inorganic Nanoparticles for Cancer Theranostics: Insights into the Degradation Behavior.
    Zhou H; Ge J; Miao Q; Zhu R; Wen L; Zeng J; Gao M
    Bioconjug Chem; 2020 Feb; 31(2):315-331. PubMed ID: 31765561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the development of nanoparticles for multimodality imaging and therapy of cancer.
    Liu M; Anderson RC; Lan X; Conti PS; Chen K
    Med Res Rev; 2020 May; 40(3):909-930. PubMed ID: 31650619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsically radiolabeled nanoparticles: an emerging paradigm.
    Goel S; Chen F; Ehlerding EB; Cai W
    Small; 2014 Oct; 10(19):3825-30. PubMed ID: 24978934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lanthanide-Activated Nanoparticles: A Toolbox for Bioimaging, Therapeutics, and Neuromodulation.
    Yi Z; Luo Z; Qin X; Chen Q; Liu X
    Acc Chem Res; 2020 Nov; 53(11):2692-2704. PubMed ID: 33103883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis?
    Pant K; Sedláček O; Nadar RA; Hrubý M; Stephan H
    Adv Healthc Mater; 2017 Mar; 6(6):. PubMed ID: 28218487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicines for Renal Management: From Imaging to Treatment.
    Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W
    Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAMAM Dendrimer-Based Nanodevices for Nuclear Medicine Applications.
    Xiao T; Li D; Shi X; Shen M
    Macromol Biosci; 2020 Feb; 20(2):e1900282. PubMed ID: 31829523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper-based nanomaterials for cancer theranostics.
    Zhong X; Dai X; Wang Y; Wang H; Qian H; Wang X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1797. PubMed ID: 35419993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graphene-based nanomaterials as molecular imaging agents.
    Garg B; Sung CH; Ling YC
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(6):737-58. PubMed ID: 25857851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent development of nanoparticles for molecular imaging.
    Kim J; Lee N; Hyeon T
    Philos Trans A Math Phys Eng Sci; 2017 Nov; 375(2107):. PubMed ID: 29038377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.